Skip to main content
. 2022 Feb 15;12:2517. doi: 10.1038/s41598-022-06547-3

Figure 1.

Figure 1

Proportion of benign and pathogenic variants in (A) Clinvitae training, PTT and test sets, (B) Clinvitae validation set, (C) ICR639 hereditary cancer dataset.